Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Epetraborole in Complicated Intra-abdominal Infection
NCT01381562Phase 2Terminated
- Sponsor
- GSK
- Start
- Oct 2011
- Primary completion
- Mar 2012
- Modality
- Small Molecules
- Countries
- 7
01
Overview
Phase 2, randomised, double-blind trial of epetraborole in Intra-abdominal infection (IAI) (3 arms), sponsored by GSK. Primary endpoints: Number of Participants With Any Adverse Event, Number of Participants With Clinically Significant Trends in Vital Signs and 5 more. Started Oct 2011; status: terminated.
02
Drugs
epetraborole
03
Conditions
Intra-abdominal infection (IAI)
Beyond the preview
Go deeper on NCT01381562.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01381562.